Literature DB >> 24729767

Patient decision tools in inflammatory bowel disease.

Corey A Siegel1.   

Abstract

Entities:  

Year:  2013        PMID： 24729767      PMCID： PMC3983975     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.

Authors:  F Reed Johnson; Brett Hauber; Semra Özdemir; Corey A Siegel; Steven Hass; Bruce E Sands
Journal:  J Manag Care Pharm       Date:  2010-10

2.  Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease.

Authors:  Corey A Siegel; Lori S Siegel; Jeffrey S Hyams; Subra Kugathasan; James Markowitz; Joel R Rosh; Neal Leleiko; David R Mack; Wallace Crandall; Jonathan Evans; David J Keljo; Anthony R Otley; Maria Oliva-Hemker; Sharmayne Farrior; Christine R Langton; Iwona T Wrobel; Ghassan Wahbeh; J Antonio Quiros; Gary Silber; Ron J Bahar; Bruce E Sands; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

Review 3.  Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options.

Authors:  Corey A Siegel
Journal:  Gut       Date:  2011-12-20       Impact factor: 23.059

Review 4.  Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease.

Authors:  Shane M Devlin; Adam S Cheifetz; Corey A Siegel
Journal:  Gastroenterol Clin North Am       Date:  2012-02-14       Impact factor: 3.806

Review 5.  Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease.

Authors:  Parambir S Dulai; Corey A Siegel; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.